GlassScriptPhysician profile
Miguel A Albert
NPI 1144385394
$807.08
in general payments reported to CMS, 2019-2025
11 companies · $288 in 2025
The $288 reported for 2025 was more than what a typical Obstetrics & Gynecology provider received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $36.83 · 2020: $41.69 · 2022: $175 · 2023: $82.21 · 2024: $184 · 2025: $288.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $554.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $553.65 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Becton, Dickinson and Company | $285.01 | 2024-2025 | Bd Onclarity, Bd Veritor Plus Analyzer |
| Exeltis, USA INC. | $140.21 | 2022-2025 | Slynd |
| Medical Device Business Services, INC. | $119.11 | 2022 | |
| Hologic Sales and Service, LLC | $79.94 | 2022-2025 | Aptima, Thinprep 2000 Processor |
| Ascend Therapeutics US, LLC | $42.05 | 2020-2023 | |
| Abbvie INC. | $41.48 | 2020-2022 | |
| Covidien LP | $25.03 | 2019 | |
| Astellas Pharma US INC | $23.39 | 2024 | Veozah |
| Gilead Sciences, INC. | $19.84 | 2025 | |
| Evofem Biosciences, INC. | $19.22 | 2025 | Solosec, Phexx, Phexxi |
| Allergan, INC. | $11.80 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Miguel Albert listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.